Traded Sep 15 – Sep 16, 2025 · largest single transaction ~$1.9K
Show all 2 transactions
Sep 15, 2025~$1.9K · 2,500 sh @ $0.75
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BKYI · NASDAQ · Services-Prepackaged Software
Bio Key International (BKYI) · oqro.io/stocks/BKYI · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$2.09−0.03 (−1.42%)
Close of Nov 16, 2026, vs Nov 13 · end-of-day, not a live quote
No open-market purchase by an insider of Bio Key International was filed in the last 90 days. The latest on record was on Sep 17, 2025.
Since 2006, Bio Key International insiders reported 117 open-market purchases and 0 sales on Forms 4 and 5, with purchases in 12 different years, most recently 2025.
No open-market sale by an insider of Bio Key International (BKYI) was filed with the SEC in the last 90 days.
No trade in Bio Key International (BKYI) was disclosed by a member of Congress in the last 12 months.
Bio Key International's next results are expected on Mar 2, 2027. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
−78.5% (−$7.65) from Nov 17, 2025 to Nov 16, 2026 · adjusted daily closes
No disclosed open-market insider trades, politician trades or fund 13F changes in this period.
Adjusted close went from $9.74 on Nov 17, 2025 to $2.09 on Nov 16, 2026 (−78.5%). Disclosed in this range: 0 insider trades, 0 pre-arranged insider sales, 0 Congress trades.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Services-Prepackaged Software company based in Holmdel, Nj.
Last 12 months
−77.9%
Market value
$4.25M
S&P 500 +10.1% over the same dates. Prices adjusted for splits and dividends.
Short interest: 271K shares sold short (13.3% of shares outstanding), −29.9% vs the previous count, 1.0 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Revenue
$1.48M
−4.3% vs the same quarter a year earlier
Free cash flow, last 12 months
−$4.48M
This quarter −$1.44M, a year earlier −$1.12M
Net debt
—
Debt —, cash $2.22M, at Sep 30, 2026
Net income, last 12 months
−$5.96M
Operating profit covers interest -129.1x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Nov 13, 2026.
Revenue, fiscal 2025
$5.94M
−14.3% vs the year before
Net income, fiscal 2025
−$7.16M
A loss for the year
Shares outstanding
2.04M
As of Nov 12, 2026
Traded Sep 15 – Sep 16, 2025 · largest single transaction ~$1.9K
Sep 15, 2025~$1.9K · 2,500 sh @ $0.75
Sep 16, 2025~$1.4K · 1,617 sh @ $0.84
DetailsOfficial recordInsider buying
Traded Aug 22, 2025 · filed 5 days later
Bio Key International's Chief Legal Officer paid $7.7K out of pocket for Bio Key International shares. 1 other person at Bio Key International bought some too, in the same month. Shares held went up 22% with this purchase.
Insider buying
Traded Jun 13, 2025 · filed 3 days later
The CEO of Bio Key International paid $3.9K out of pocket for Bio Key International shares. Shares held went up 10% with this purchase.
Insider buying
Traded Jun 3, 2025 · filed 1 day later
The CEO of Bio Key International paid $3.3K out of pocket for Bio Key International shares. Shares held went up 9% with this purchase.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Fails to deliver: 501K shares (about $1.42M) were not delivered on time for settlement on Oct 14, 2026. SEC fails-to-deliver data.
Fails to deliver have many causes, including processing delays, and are often resolved within days.
Insiders of Bio Key International reported 117 open-market purchases and 0 sales since 2006; purchases in 12 different years, most recently 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | $22K6×6 trades | — |
| 2023 | $111K20×20 trades | — |
| 2022 | $35K14×14 trades | — |
| 2021 | $91K12×12 trades | — |
| 2020 | $64K6×6 trades | — |
| 2018 | $362K3×3 trades | — |
| 2017 | $2.62M7×7 trades | — |
| 2016 | $3.42M28×28 trades | — |
| 2015 | $9K3×3 trades | — |
| 2011 | $20K8×8 trades | — |
| 2010 | $15K5×5 trades | — |
| 2006 | $42K5×5 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Last results
Nov 13, 2026
Within the 30 days after it, until Dec 13, 2026
Next results, expected
Mar 2, 2027
Purchases after results
80%
94 of 117 insider purchases since 2006 came within 30 days after a results announcement
From Bio Key International's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Bio Key International's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Changed auditor
8-K on sec.govNotice of delisting or failure to meet listing rules
8-K on sec.govSaid its annual or quarterly report would be late
NT 10-Q on sec.govNotice of delisting or failure to meet listing rules
8-K on sec.govNotice of delisting or failure to meet listing rules
8-K on sec.govSaid its annual or quarterly report would be late
NT 10-K on sec.govNotice of delisting or failure to meet listing rules
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.